CC(C)N(C(=O)[C@H]1C[C@H](CC(=O)NCC23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)C(=O)N2CCc3c([nH]c4cc(-c5ccco5)ccc34)[C@]12C)C(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?